EP3307357

SANOFI AVENTIS DEUTSCHLAND
Application Number
EP16729241A
Filing Date
Jun 9, 2016
Status
Patent Maintained As Amended
May 5, 2023
Grant Date
Jun 7, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition

Bibliography

The patent EP3307357B2 was granted to Sanofi Aventis Deutschland on Jun 7, 2023 following the initial filing on Jun 9, 2016 under the application number EP16729241A . The current legal status of the patent is Patent Maintained As Amended.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

DI CARE ZRTFeb 8, 2021ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents